EuroAPI Header EuroAPI Header

X

Digital content for CSPC Pharmaceutical Group

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
CSPC Pharmaceutical Group
China Flag
Country
Country
China
Address
Address
No.896 Zhongshan East Road,Shijiazhuang, Hebei Province,PRC 050035
Telephone
Telephone
+86 31187037015
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-cspc-pharmas-rsv-vaccine-clinical-trials-2024-07-12/

REUTERS
12 Jul 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-braces-generic-challenge-ozempic-wegovy-china-2024-06-05/

Andrew Silver REUTERS
06 Jun 2024

https://doc.irasia.com/listco/hk/cspc/announcement/a240603.pdf

PRESS RELEASE
03 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/who-says-wider-alert-contaminated-jj-cough-syrup-likely-2024-04-19/

Andrew Silver REUTERS
19 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharma-partners-with-pfizer-covid-oral-treatment-2023-06-29/

REUTERS
29 Jun 2023

https://www.prnewswire.com/news-releases/elevation-oncology-highlights-clinical-data-for-sysa1801-eo-3021-to-be-presented-by-partner-cspc-pharmaceutical-group-limited-at-asco-2023-301808646.html

PR NEWSWIRE
26 Apr 2023

https://economictimes.indiatimes.com/news/international/world-news/china-okays-its-first-mrna-vaccine-from-drugmaker-cspc/articleshow/98918764.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
23 Mar 2023

https://www.prnewswire.com/news-releases/hanalls-licensed-partner-in-china-enters-sublicense-agreement-with-cspc-to-further-accelerate-development-of-batoclimab-301645449.html

PRNEWSWIRE
11 Oct 2022

https://www.prnewswire.com/news-releases/elevation-oncology-expands-pipeline-through-exclusive-licensing-of-eo-3021-sysa1801-a-clinical-stage-anti-claudin18-2-antibody-drug-conjugate-from-cspc-pharmaceutical-group-301595313.html

PRNEWSWIRE
28 Jul 2022

https://www.asiaone.com/business/ind-approved-pivotal-clinical-study-her2-bispecific-antibody-kn026-combined-chemotherapy

ASIAONE
05 Jan 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY